Analysts/Institutional Investor Meet/Con. Call Updates Laurus Labs Limited has informed the Exchange about Transcript · 2026-01-23
I have question for Dr. Chava and thank you for the opportunity. Sir, I have question on CDMO space, like we have been seeing many of the Indian pharma players they have been expanding towards this CDMO segment. So, as per the understanding how big and long is this opportunity and given that Laurus has invested so much in the last couple of years towards expanding the capability and capacity, so what is the competitive advantage that Laurus Labs have as compared to its peers. So, that's one of my questions.
Okay, so as per you or whatever we say competitive that you talked about , so is it a fa ir assumption that developing these capabilities is a very long -term process and any pharma company just cannot hire a scientist and let's foray into these because they are very skillful operations? So, is it fair that developing these and getting the cust omer approval is a very big thing because the capability matters a lot as compared to the capacity. So, is it a fair assumption?